Trials / Terminated
TerminatedNCT03026803
A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
A Phase II Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- City of Hope Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This phase II trial is studying how well giving oxaliplatin and capecitabine together works in treating patients with liver cancer.
Detailed description
Drugs used in chemotherapy, such as oxaliplatin and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving these drugs together may kill more tumor cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin | Given IV |
| DRUG | Capecitabine | Given PO |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2017-01-20
- Last updated
- 2017-04-13
- Results posted
- 2017-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03026803. Inclusion in this directory is not an endorsement.